Chinese Japanese Germany Korea

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Structure
N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine structure
CAS No.
95259-48-6
Chemical Name:
N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine
Synonyms
Nikkomycin QX;N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine;L-Homoserine, (3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl-(2S)-2-[(2R,3S,4R,5R)-5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl]glycyl- (9CI);(2S)-2-[[(2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(5-formyl-2-oxo-1H-imidazol-3-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]-4-hydroxybutanoic acid
CBNumber:
CB52335758
Molecular Formula:
C24H32N6O12
Molecular Weight:
596.54
MDL Number:
MOL File:
95259-48-6.mol
Request For Quotation

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Properties

Density 1.651±0.06 g/cm3(Predicted)
pka 3.06±0.10(Predicted)

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Preparation Products And Raw materials

Raw materials

Preparation Products

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Nikkomycin QX (2S)-2-[[(2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(5-formyl-2-oxo-1H-imidazol-3-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]-4-hydroxybutanoic acid L-Homoserine, (3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl-(2S)-2-[(2R,3S,4R,5R)-5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl]glycyl- (9CI) 95259-48-6